# DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
> **ANDA211876** · Abbreviated New Drug Application (Generic) · Sponsor: AUROLIFE PHARMA LLC · Approved 2020-06-24
## Drug
- **FDA Application Number:** ANDA211876
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
- **Generic name:** Amphetamine Aspartate
- **Active ingredients:** AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AUROLIFE PHARMA LLC
- **First approval:** 2020-06-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211876)
---
*MORVS · CC0 1.0*